Phase 2 Genodermatosis Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 2
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses
IchthyosisEpidermolysis Bullosa SimplexGenodermatosis+1 more
Centre Hospitalier Universitaire de Nice10 enrolled2 locationsNCT06136403
Recruiting
Phase 2
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
Epidermolysis Bullosa SimplexGenodermatosis
Centre Hospitalier Universitaire de Nice20 enrolled4 locationsNCT06509984